Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era-Reference-Cited by-同舟云学术

Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era

Author:

Davis M. K.¹^ORCID,Kale P.²,Liedtke M.³,Schrier S.³,Arai S.⁴,Wheeler M.¹,Lafayette R.⁵,Coakley T.¹,Witteles R. M.¹

Affiliation:

1. Division of Cardiovascular Medicine and Stanford Cardiovascular Institute; Stanford University School of Medicine; Stanford CA

2. Heart Transplant; Kaiser Permanente Northern California; Santa Clara CA

3. Division of Hematology; Stanford University School of Medicine; Stanford CA

4. Division of Blood and Marrow Transplant; Stanford University School of Medicine; Stanford CA

5. Division of Nephrology; Stanford University School of Medicine; Stanford CA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference31 articles.

3. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases;Kyle;Semin Hematol,1995

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献